4.8 Article

The impact of graphene oxide sheet lateral dimensions on their pharmacokinetic and tissue distribution profiles in mice

期刊

JOURNAL OF CONTROLLED RELEASE
卷 338, 期 -, 页码 330-340

出版社

ELSEVIER
DOI: 10.1016/j.jconrel.2021.08.028

关键词

Graphene oxide; Functionalization; Pharmacokinetics; Nanomedicine; pharmacology

资金

  1. EU 7th RTD Framework Programme, Graphene Flagship project (FP7-ICT-2013-FET-F) [604391]
  2. Agence Nationale de la Recherche (ANR) through the LabEx project Chemistry of Complex Systems [ANR-10-LABX-0026_CSC]

向作者/读者索取更多资源

This study investigated the pharmacokinetics of graphene oxide (GO) sheets with different lateral dimensions in living systems. The results showed that GO materials of different sizes were sequestered by the spleen and liver, with significant accumulation in the lungs observed for large materials. Interestingly, all three GO nanomaterials exhibited extensive urinary excretion, indicating that excretion was not affected by lateral dimensions.
Although the use of graphene and 2-dimensional (2D) materials in biomedicine has been explored for over a decade now, there are still significant knowledge gaps regarding the fate of these materials upon interaction with living systems. Here, the pharmacokinetic profile of graphene oxide (GO) sheets of three different lateral dimensions was studied. The GO materials were functionalized with a PEGylated DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid), a radiometal chelating agent for radioisotope attachment for single photon emission computed tomography (SPECT/CT) imaging. Our results revealed that GO materials with three distinct size distributions, large (l-GO-DOTA), small (s-GO-DOTA) and ultra-small (us-GO-DOTA), were sequestered by the spleen and liver. Significant accumulation of the large material (l-GO-DOTA) in the lungs was also observed, unlike the other two materials. Interestingly, there was extensive urinary excretion of all three GO nanomaterials indicating that urinary excretion of these structures was not affected by lateral dimensions. Comparing with previous studies, we believe that the thickness of layered nanomaterials is the predominant factor that governs their excretion rather than lateral size. However, the rate of urinary excretion was affected by lateral size, with large GO excreting at slower rates. This study provides better understanding of 2D materials in vivo behaviour with varying structural features.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据